Brief: Tempus Receives Ivdr Certification For Xr Rna Sequencing For Solid Tumor Profiling
BRIEF-Tempus Receives Ivdr Certification For Xr Rna Sequencing For Solid Tumor Profiling Oct 26 (Reuters) - Tempus AI, Inc. TEM.O:
TEMPUS RECEIVES IVDR CERTIFICATION FOR XR RNA SEQUENCING FOR SOLID TUMOR PROFILING
Source text: ID:nBw2n7rnta
Further company coverage: TEM.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Tempus AI
See all newsU.S. STOCKS ON THE MOVE-Tempus AI, Choice Hotels, Palantir
Tempus AI rises after surprise quarterly profit
Tempus AI Q3 revenue slightly beats estimates; raises guidance
Brief: Tempus Receives Ivdr Certification For Xr Rna Sequencing For Solid Tumor Profiling
Brief: Tempus Expands Strategic Collaboration With Bristol Myers Squibb